Status:
COMPLETED
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
Lead Sponsor:
Taipei Medical University Hospital
Collaborating Sponsors:
National Science and Technology Council, Taiwan
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Conditions:
Schizophrenia
Antipsychotics
Eligibility:
All Genders
18-60 years
Brief Summary
Schizophrenia is one of the most severe mental illnesses. The antipsychotic drugs, introduced in early 1950s, have revolutionized the treatment of schizophrenia. About 2 to 4 times as many patients re...
Eligibility Criteria
Inclusion
- clinical diagnosis of schizophrenia
- age 18-60 years
Exclusion
- received any SGAs prior to this study
- medical conditions that may confound glucoregulatory assessment
- pregnancy
Key Trial Info
Start Date :
March 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00937755
Start Date
March 1 2006
End Date
May 1 2009
Last Update
July 13 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University-Municipal Wan-Fang Hospital
Taipei, Taiwan, 116